Balentine LLC’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-11,770
Closed -$1.12M 307
2024
Q1
$1.12M Buy
11,770
+6,937
+144% +$663K 0.03% 173
2023
Q4
$369K Buy
+4,833
New +$369K 0.01% 349
2023
Q3
Sell
-4,317
Closed -$407K 574
2023
Q2
$407K Buy
4,317
+1,173
+37% +$111K 0.01% 313
2023
Q1
$260K Buy
+3,144
New +$260K 0.01% 456
2022
Q4
Sell
-4,816
Closed -$398K 660
2022
Q3
$398K Buy
4,816
+1,123
+30% +$92.8K 0.02% 331
2022
Q2
$351K Sell
3,693
-810
-18% -$77K 0.01% 394
2022
Q1
$530K Buy
4,503
+1,986
+79% +$234K 0.02% 282
2021
Q4
$326K Buy
2,517
+461
+22% +$59.7K 0.01% 238
2021
Q3
$233K Buy
+2,056
New +$233K 0.01% 216
2020
Q3
Sell
-576
Closed -$40K 387
2020
Q2
$40K Buy
576
+72
+14% +$5K ﹤0.01% 274
2020
Q1
$32K Sell
504
-624
-55% -$39.6K ﹤0.01% 221
2019
Q4
$88K Buy
1,128
+600
+114% +$46.8K ﹤0.01% 130
2019
Q3
$39K Buy
528
+66
+14% +$4.88K ﹤0.01% 156
2019
Q2
$28K Buy
462
+78
+20% +$4.73K ﹤0.01% 172
2019
Q1
$24K Hold
384
﹤0.01% 190
2018
Q4
$20K Hold
384
﹤0.01% 190
2018
Q3
$22K Buy
+384
New +$22K ﹤0.01% 131
2018
Q1
Sell
-3,705
Closed -$139K 215
2017
Q4
$139K Buy
3,705
+870
+31% +$32.6K 0.01% 160
2017
Q3
$103K Buy
2,835
+1,245
+78% +$45.2K 0.01% 182
2017
Q2
$63K Sell
1,590
-741
-32% -$29.4K 0.01% 216
2017
Q1
$73K Buy
2,331
+2,079
+825% +$65.1K 0.01% 191
2016
Q4
$8K Buy
252
+54
+27% +$1.71K ﹤0.01% 423
2016
Q3
$8K Hold
198
﹤0.01% 377
2016
Q2
$7K Buy
+198
New +$7K ﹤0.01% 382